Thomas Zindrick

Mr. Zindrick has served on the Board of Directors and has been President and CEO since 2014, and also serves as a member of the Board of Managers of V2ACT Therapeutics LLC.

Tom is an accomplished senior executive with diverse experience in life sciences companies. From 1993 to 2009, Tom held positions of increasing responsibility at Amgen, Inc., including Vice President, Associate General Counsel and Chief Compliance Officer. Prior to joining Amgen, Tom was an attorney at The Dow Chemical Company.

Tom currently serves as Executive Chairman of Aeromics, Inc., a clinical-stage pharmaceutical company developing products for the control of edema (brain swelling) in ischemic stroke. He previously served on the board of directors of Amitech Therapeutic Solutions, Inc. from 2011 to February 2021 and DNX Biopharmaceuticals, Inc. from November 2014 to March 2020.

Tom received his J.D. from the University of Illinois College of Law and a B.A. in Biology from North Central College in Naperville, Illinois.